Princess Margaret cancer center

Toronto M5G2M9

3 studies enrolling now · 10 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Malignant Neoplasm, Advanced Solid Tumor, Chronic Myelomonocytic Leukemia, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Giant Cell Tumor of Tendon Sheath, Leukemia, Metastatic Solid Tumor, Myelodysplastic Syndromes, Osteosarcoma, Osteosarcoma in Adolescents and Young Adults

Studies at this site

• A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer — Recruiting now
• First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors — Recruiting now
• A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) — Enrolling by invitation
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
• Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor — Running, not enrolling
• Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) — Running, not enrolling
• Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma — Stopped early
• Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors — Running, not enrolling
• REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 — Stopped early
• A Prospective Natural History Study in Uveal Melanoma — Running, not enrolling